FMP

FMP

Enter

LYEL - Lyell Immunopharma, Inc.

Valuation of Lyell Immunopharma, Inc.(LYEL), Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for

Valuation Date:

Mar 28, 2024 3:00 PM

Share Price on Valuation Date

$2.23

Stock Beta

-0.509

Shares Outstanding

254096000

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep